Study design
T2DM, Diabetes
DIABETES
After a 2-week washout period, 17 patients clinically diagnosed with T2DM enrolled in the clinical trial and were randomly assigned into two groups using the SAS software. As an open-label, parallel-group study, the control group (n = 8 patients) received usual care, including patient education and dietary recommendations based on the 2013 Chinese Diabetes Society guidelines for T2DM; the treatment group (n = 9 patients) received whole grains, prebiotics, and traditional Chinese medicinal foods composed high-fiber diet. The high-fiber diet for the treatment group consisted of several whole grains and traditional Chinese medicinal food (shown in The components of the high fiber diet.The recruited participants received either acarbose (100 mg; 3 times/day) plus common diet for T2DM (control group) or acarbose (100 mg; 3 times/day) plus the high fiber diet (treatment group) for 8 weeks, while all the patients received the same total caloric and macronutrients prescriptions and followed the exercises advice according to the Chinese Diabetes Society.